Diamondrock Hospitality Co
Change company Symbol lookup
Select an option...
DRH Diamondrock Hospitality Co
BBW Build-A-Bear Workshop Inc
GWPH GW Pharmaceuticals PLC
LMT Lockheed Martin Corp
TELL Tellurian Inc
PFE Pfizer Inc
AGNC Agnc Investment Corp
AAPL Apple Inc
GRTYA Guaranty Corp
SATS EchoStar Corp
Go

Real Estate : Equity Real Estate Investment Trusts (REITs) | Small Cap Value
Company profile

DiamondRock Hospitality Company is a real estate investment trust (REIT). As of December 31, 2016, the Company owned a portfolio of 26 hotels and resorts that contains 9,472 guest rooms located in 17 different markets in North America and the United States Virgin Islands. Its business is to acquire, own, asset manage and renovate hotel properties in the United States. Its portfolio is concentrated in gateway cities and destination resort locations. It conducts its business through an umbrella partnership REIT (UPREIT) in, which its hotels are owned by subsidiaries of its operating partnership, DiamondRock Hospitality Limited Partnership. The Company is the general partner of its operating partnership and owns, either directly or indirectly, all of the limited partnership units of its operating partnership. The Company leases all of its domestic hotels to taxable REIT subsidiary, Bloodstone TRS, Inc. (TRS) lessees.

Postmarket

Last Trade
Delayed
$0.00
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$8.72
Day's Change
0.30 (3.56%)
Bid
--
Ask
--
B/A Size
--
Day's High
8.93
Day's Low
8.40
Volume
(Heavy Day)
Volume:
9,208,675

10-day average volume:
3,600,119
9,208,675

[2019-2026], Host Cell Contaminant Testing Market Size, Share, Growth, Trends, Revenue, Analysis, Competitive Landscape, Forecast

7:58 am ET November 17, 2020 (Globe Newswire) Print

The global Host Cell Contaminant Testing Market will derive growth from the massive investments in product R&D. Recent discoveries that have indicated the properties to treat severe diseases such as cancer will bode well for market growth. According to a report by Fortune Business Insights. The market will benefit from the increasing healthcare budgets across the world. Host cell contaminant testing is the study of biologics from living sources such as bacteria, yeasts, and fungi. The process is used for research and development process in critical diseases such as cancer. North America is projected to emerge dominant in the coming years. The increasing number of research activities will have a huge impact on the growth of the regional market.

Industry Developments:

August 2019: Bio-Techne announced that it has partnered with Cygnus Technologies; a step that is aimed at the quantification of Chinese hamster ovary host cell proteins (CHO-HCP) on the ProteinSimple branded Ella immunoassay platform.

June 2019: Cygnus Technologies announced that it will be expanding its service offerings for host cell protein (HCP) impurities detection. The company claims that the product is also used for identification and quantification which can impact the efficacy and stability of the therapeutic.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/host-cell-contaminant-testing-market-103115

The increasing number of research activities associated with the testing will have a massive impact on the growth of the overall host cell contaminant testing market in the coming years. The presence of several large scale companies as well as SMEs in this sector will bode well for the growth of the overall market in the coming years.

The increasing number of regulatory approvals associated with the testing equipment will have a massive impact on the growth of the overall host cell contaminant testing market in the foreseeable future.

Thermo Fisher's 'Torrent Genexus System' is a Major Highlight of Recent Times

The report highlights a few of the major factors that have contributed to the growth of the overall market in recent years. The massive investments in product R&D have yielded a few exceptional products in recent years and increasing number of such innovations have had a subsequent impact on market growth.

In November 2019, Thermo Fisher Scientific announced the launch of a new product in the host cell contaminant testing space. The company introduced 'Torrent Genexus System,' a product that is described as the first fully integrated next-gen sequencing platform. The company claims that the product includes an automated specimen-to-report workflow that is capable of delivering efficient results in a single day.

Click here to get the short-term and long-term impact of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/host-cell-contaminant-testing-market-103115

List of companies profiled in the Host Cell Contaminant Testing Market report:

-- Cisbio Bioassays

-- Cygnus Technologies

-- Bio-Rad Laboratories Inc.

-- Enzo Life Sciences Inc.

-- BioGenes

-- Molecular Devices LLC.

-- ForteBio

-- GENERAL ELECTRIC COMPANY

-- Thermo Fisher Scientific

-- ProteinSimple.

-- Bio-Techne

-- BioAgilytix Labs

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/host-cell-contaminant-testing-market-103115

North America to Emerge Dominant; Increasing Investments in Research Activities will bode well for Market Growth

The report analyses the ongoing market trends across five major regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Among all regions, the market in North America is projected to emerge dominant in the coming years. The increasing number of research activities will have a huge impact on the growth of the regional market.

The number of clinical trials associated with host cell contaminants is high in United States. The improving healthcare infrastructures, coupled with the rising healthcare budgets in the United States will bode well for the growth of the market in North America.

Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/host-cell-contaminant-testing-market-103115

Host Cell Contaminant Testing Market Segmentations:

By Type

? Microbial

? Mammalian

? Others

By Test

? PCR

? Immunoassay

? Others

By End-Users

? Pharmaceutical & Biotechnology Industries

? Academic & Research Institutes

? Diagnostic Centres

? Others

By Geography

? North America (USA, Canada)

? Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

? Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)

? Latin America (Brazil, Mexico, Rest of Latin America)

? Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)

SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:

-- Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies

-- Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.

-- Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility

-- Number of procedures and average price of procedures

-- Replacement rate and pricing of capital equipment

-- Market dynamics in relation to the market under focus - Drivers, restraints, trends, and opportunities

-- Market & technological trends, new product developments, product pipeline.

Have a Look at Related Reports:

Ventilator Market Share & Covid-19 Impact Analysis, By Type (Adult, and Paediatric & Neonatal), By Interface (Invasive, and Non-invasive), By End User (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2020-2027

C-arms Market Share & Industry Analysis, By Type (Fixed, Mobile), By Application (Or-thopedics and Trauma, Cardiology, Neurology, Gastroenterology, Oncology, and Others), By Detector (Flat Panel Detector, and Image Intensifier), By End User (Hospitals, Diagnostic Centers, Clinics and Others) and Regional Forecast, 2020-2027

Cancer Cachexia Market Share & Covid-19 Impact Analysis, By Product (Progestogens, Corticosteroids, Combination Therapies, and Others), By Distributional Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027

Wound Care Market Share & Covid-19 Impact Analysis, By Type (Advanced Wound Dressing, Traditional Wound Care Products, Negative Pressure Wound Therapy, Bioactives, and Others), By Application (Chronic Wounds, and Acute Wounds), By End User (Hospitals, Clinics, Homecare Settings, and Others), and Regional Forecast, 2020-2027

COVID-19 Diagnostics Market Share & Industry Analysis, By Product (Instruments and Reagents & Kits), By Technology (PCR (Polymerase Chain Reaction), ELISA (Enzyme-linked Immunosorbent Assay), Point-of-care (POC), and Others), By Sample Type (Oropharyngeal and Nasopharyngeal Swabs, Blood, Urine, and Others), By End User (Hospitals & Clinics, Laboratories & Diagnostic Centers, and Research Institutes), and Regional Forecast, 2020-2027

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights(TM) Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Fortune Business Insights(TM)

LinkedIn | Twitter | Blogs

https://ml.globenewswire.com/media/05408ba1-26b1-4fdd-8f48-1af4df373348/small/fbi-logo-tm-png.png

https://ml.globenewswire.com/media/05408ba1-26b1-4fdd-8f48-1af4df373348/small/fbi-logo-tm-png.png

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.